CAR-T Therapy Leads to Myasthenia Gravis Improvements

(MedPage Today) — SAN FRANCISCO — Descartes-08, an autologous, B-cell maturation antigen (BCMA)-directed mRNA chimeric antigen receptor (CAR) T-cell therapy, led to sustained responses in generalized myasthenia gravis (MG), a phase IIb trial…